249 related articles for article (PubMed ID: 28956834)
1. The Emerging Role of Zinc in the Pathogenesis of Multiple Sclerosis.
Choi BY; Jung JW; Suh SW
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28956834
[TBL] [Abstract][Full Text] [Related]
2. Zinc transporter 3 (ZnT3) gene deletion reduces spinal cord white matter damage and motor deficits in a murine MOG-induced multiple sclerosis model.
Choi BY; Kim IY; Kim JH; Kho AR; Lee SH; Lee BE; Sohn M; Koh JY; Suh SW
Neurobiol Dis; 2016 Oct; 94():205-12. PubMed ID: 27370228
[TBL] [Abstract][Full Text] [Related]
3. A Novel Zinc Chelator, 1H10, Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating Zinc Toxicity and AMPK Activation.
Choi BY; Jeong JH; Eom JW; Koh JY; Kim YH; Suh SW
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397660
[TBL] [Abstract][Full Text] [Related]
4. Copper/zinc chelation by clioquinol reduces spinal cord white matter damage and behavioral deficits in a murine MOG-induced multiple sclerosis model.
Choi BY; Jang BG; Kim JH; Seo JN; Wu G; Sohn M; Chung TN; Suh SW
Neurobiol Dis; 2013 Jun; 54():382-91. PubMed ID: 23360710
[TBL] [Abstract][Full Text] [Related]
5. The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
Rawji KS; Yong VW
Clin Dev Immunol; 2013; 2013():948976. PubMed ID: 23840244
[TBL] [Abstract][Full Text] [Related]
6. Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
Adzemovic MV; Zeitelhofer M; Eriksson U; Olsson T; Nilsson I
PLoS One; 2013; 8(2):e56586. PubMed ID: 23437178
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.
Evonuk KS; Baker BJ; Doyle RE; Moseley CE; Sestero CM; Johnston BP; De Sarno P; Tang A; Gembitsky I; Hewett SJ; Weaver CT; Raman C; DeSilva TM
J Immunol; 2015 Jul; 195(2):450-463. PubMed ID: 26071560
[TBL] [Abstract][Full Text] [Related]
8. Effect of natalizumab treatment on metalloproteinases and their inhibitors in a mouse model of multiple sclerosis.
Pyka-Fosciak G; Lis GJ; Litwin JA
J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32776909
[TBL] [Abstract][Full Text] [Related]
9. Astrocytes in Multiple Sclerosis-Essential Constituents with Diverse Multifaceted Functions.
Aharoni R; Eilam R; Arnon R
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072790
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
11. Absence of system x
Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
[TBL] [Abstract][Full Text] [Related]
12. Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse.
Wang XS; Fang HL; Chen Y; Liang SS; Zhu ZG; Zeng QY; Li J; Xu HQ; Shao B; He JC; Hou ST; Zheng RY
Eur J Pharmacol; 2014 Aug; 736():70-6. PubMed ID: 24797785
[TBL] [Abstract][Full Text] [Related]
13. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models.
Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M
Cells; 2021 Apr; 10(4):. PubMed ID: 33924474
[TBL] [Abstract][Full Text] [Related]
14. Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
Elieh-Ali-Komi D; Cao Y
Clin Rev Allergy Immunol; 2017 Jun; 52(3):436-445. PubMed ID: 28025778
[TBL] [Abstract][Full Text] [Related]
15. Autophagy modulation in multiple sclerosis and experimental autoimmune encephalomyelitis.
Shen D; Liu K; Wang H; Wang H
Clin Exp Immunol; 2022 Aug; 209(2):140-150. PubMed ID: 35641229
[TBL] [Abstract][Full Text] [Related]
16. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis.
Uchida Y; Sumiya T; Tachikawa M; Yamakawa T; Murata S; Yagi Y; Sato K; Stephan A; Ito K; Ohtsuki S; Couraud PO; Suzuki T; Terasaki T
Mol Neurobiol; 2019 Mar; 56(3):2039-2056. PubMed ID: 29984400
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Hu X; Qin X
Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
[TBL] [Abstract][Full Text] [Related]
19. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
20. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
Yin LL; Lin LL; Zhang L; Li L
Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
